Effect of previous hormone replacement therapy on endometrial polyps during menopause

Gynecol Endocrinol. 2004 Jun;18(6):299-304. doi: 10.1080/09513590410001729897.

Abstract

The aim of this study was to evaluate the effect of hormone replacement therapy (HRT) on the expression of Ki-67, bcl-2 and c-erb.B2 in endometrial polyps during menopause. Sixteen patients using HRT and 24 untreated controls with endometrial polyps were enrolled in this study. Polypectomy was carried out by hysteroscopy. The presence of c-erb.B2, bcl-2 and Ki-67 expression was determined by immunohistochemistry. HRT was found to decrease Ki-67 and bcl-2 expression in endometrial polyps without affecting the c-erb.B2 staining reaction. HRT may cause endometrial polyp involution by decreasing proliferation and stimulating apoptosis.

MeSH terms

  • Administration, Cutaneous
  • Administration, Oral
  • Aged
  • Case-Control Studies
  • Endometrial Neoplasms / metabolism*
  • Estradiol / pharmacology
  • Estrogen Replacement Therapy*
  • Estrogens, Conjugated (USP) / pharmacology
  • Female
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / metabolism
  • Medroxyprogesterone Acetate / pharmacology
  • Menopause
  • Middle Aged
  • Norethindrone / analogs & derivatives*
  • Norethindrone / pharmacology
  • Norethindrone Acetate
  • Polyps / metabolism*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Receptor, ErbB-2 / metabolism
  • Retrospective Studies

Substances

  • Estrogens, Conjugated (USP)
  • Ki-67 Antigen
  • Proto-Oncogene Proteins c-bcl-2
  • Estradiol
  • Norethindrone Acetate
  • Medroxyprogesterone Acetate
  • Receptor, ErbB-2
  • Norethindrone